Rxo, Inc. · NYSE:RXO
MFN Partners, LP reported a 19.20% stake in Rxo, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
MFN Partners, LP reported a 19.20% stake in Rxo, Inc., 32,154,993 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 19.20%
- Shares
- 32,154,993
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MFN Partners, LP | 19.20% | 32,154,993 |
| MFN Partners GP, LLC | 19.20% | 32,154,993 |
| MFN Partners Management, LP | 19.20% | 32,154,993 |
| MFN Partners Management, LLC | 19.20% | 32,154,993 |
| Michael F. DeMichele | 19.20% | 32,154,993 |
| Farhad Nanji | 19.20% | 32,154,993 |
Source
Related
- Rxo, Inc.
- MFN Partners, LP
- Rxo, Inc. shareholders
- Schedule 13D · MFN Partners, LP · Oct 5, 2026
- Form 4 · Harris James E · Sep 29, 2026
- Form 4 · Firestone Jeffrey D. · Aug 25, 2026
- Schedule 13G/A · Finepoint Capital LP · Aug 13, 2026
- Form 4 · Wilkerson Andrew M. · May 19, 2026
- Schedule 13G/A · Orbis Investment Management LTD · May 15, 2026